Establishment Labs Stock Forecast, Price & News

-3.50 (-4.61 %)
(As of 07/27/2021 04:30 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume114,816 shs
Average Volume105,339 shs
Market Capitalization$1.71 billion
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ESTA News and Ratings via Email

Sign-up to receive the latest news and ratings for Establishment Labs and its competitors with MarketBeat's FREE daily newsletter.

Establishment Labs logo

About Establishment Labs

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand. It also provides Divina 3D surgical simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.42 out of 5 stars

Medical Sector

1108th out of 2,218 stocks

Surgical Appliances & Supplies Industry

23rd out of 41 stocks

Analyst Opinion: 1.5Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Establishment Labs (NASDAQ:ESTA) Frequently Asked Questions

Is Establishment Labs a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Establishment Labs in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Establishment Labs stock.
View analyst ratings for Establishment Labs
or view top-rated stocks.

What stocks does MarketBeat like better than Establishment Labs?

Wall Street analysts have given Establishment Labs a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Establishment Labs wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Establishment Labs' next earnings date?

Establishment Labs is scheduled to release its next quarterly earnings announcement on Thursday, July 29th 2021.
View our earnings forecast for Establishment Labs

How can I listen to Establishment Labs' earnings call?

Establishment Labs will be holding an earnings conference call on Thursday, July 29th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Establishment Labs' earnings last quarter?

Establishment Labs Holdings Inc. (NASDAQ:ESTA) posted its quarterly earnings results on Wednesday, May, 5th. The company reported ($0.29) EPS for the quarter, topping analysts' consensus estimates of ($0.34) by $0.05. The company had revenue of $30.34 million for the quarter, compared to analyst estimates of $25.20 million. Establishment Labs had a negative net margin of 30.17% and a negative trailing twelve-month return on equity of 35.32%.
View Establishment Labs' earnings history

How has Establishment Labs' stock price been impacted by COVID-19?

Establishment Labs' stock was trading at $15.15 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ESTA stock has increased by 377.8% and is now trading at $72.38.
View which stocks have been most impacted by COVID-19

What guidance has Establishment Labs issued on next quarter's earnings?

Establishment Labs issued an update on its second quarter 2021 earnings guidance on Monday, July, 26th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $31 million-$32 million, compared to the consensus revenue estimate of $28.92 million.

What price target have analysts set for ESTA?

3 brokerages have issued 12-month price objectives for Establishment Labs' shares. Their forecasts range from $23.00 to $88.00. On average, they anticipate Establishment Labs' share price to reach $63.67 in the next twelve months. This suggests that the stock has a possible downside of 12.0%.
View analysts' price targets for Establishment Labs
or view top-rated stocks among Wall Street analysts.

Who are Establishment Labs' key executives?

Establishment Labs' management team includes the following people:
  • Mr. Juan Jose Chacon Quiros, Founder, CEO & Exec. Director (Age 49, Pay $598.16k)
  • Ms. Renee M. Gaeta, Chief Financial Officer (Age 40, Pay $480.39k)
  • Mr. Salvador Santos Dada, Chief Operating Officer (Medical Leave of Absence) (Age 38, Pay $468.62k)
  • Mr. Pratip Dastidar, Head of Global Operations (Age 58)
  • Mr. Roberto De Mezerville, Chief Technology Officer (Age 41)
  • David K. Erickson, VP of Investor Relations
  • Mr. Rajbir Singh Denhoy, Head of Strategy & Investor Relations
  • Ms. Neeta Toprani, Gen. Counsel & Corp. Sec.
  • Dr. Heather Brennan, Head of U.S. Commercial Operations
  • Mr. Eddie De Oliveira, VP of Sales, Brazil (Age 39)

Who are some of Establishment Labs' key competitors?

What other stocks do shareholders of Establishment Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Establishment Labs investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Sientra (SIEN), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM), (CNDT), Canadian Natural Resources (CNQ), Chevron (CVX) and Evolus (EOLS).

When did Establishment Labs IPO?

(ESTA) raised $50 million in an IPO on Thursday, July 19th 2018. The company issued 3,100,000 shares at a price of $15.00-$17.00 per share. Jefferies and Cowen served as the underwriters for the IPO and BTIG was co-manager.

What is Establishment Labs' stock symbol?

Establishment Labs trades on the NASDAQ under the ticker symbol "ESTA."

How do I buy shares of Establishment Labs?

Shares of ESTA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Establishment Labs' stock price today?

One share of ESTA stock can currently be purchased for approximately $72.38.

How much money does Establishment Labs make?

Establishment Labs has a market capitalization of $1.71 billion and generates $84.68 million in revenue each year. The company earns $-38,120,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis.

How many employees does Establishment Labs have?

Establishment Labs employs 638 workers across the globe.

What is Establishment Labs' official website?

The official website for Establishment Labs is

Where are Establishment Labs' headquarters?

Establishment Labs is headquartered at Building B15 and 25 Coyol Free Zone, Alajuela G2, .

How can I contact Establishment Labs?

Establishment Labs' mailing address is Building B15 and 25 Coyol Free Zone, Alajuela G2, . The company can be reached via phone at 506 2434 2400 or via email at [email protected]

This page was last updated on 7/27/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.